In head and neck squamous cell carcinoma (HNSCC) patients, the loss of RIPK1 and RIPK3 function caused by promoter hypermethylation is closely related with poor prognoses (63, 64). Here, RIPK3 is linked to head and neck squamous cell carcinoma.